Does Combined Clinical and Ultrasound Assessment Allow Selection of Individuals With Rheumatoid Arthritis for Sustained Reduction of Anti–Tumor Necrosis Factor Therapy?

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|6|746-753

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.6, 2015-05, pp. : 746-753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 6, 2015-05 ,pp. : 842-847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 8, 2015-05 ,pp. : 2011-2019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medication Persistence of Disease‐Modifying Antirheumatic Drugs and Anti–Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil

By  

ARTHRITIS CARE AND RESEARCH, Vol. 68, Iss. 10, 2016-10 ,pp. : 1489-1496

John Wiley & Sons Inc

Access to resources Recommend Favorite

ANCA‐positive crescentic glomerulonephritis in a patient with rheumatoid arthritis treated with anti‐tumor necrosis factor alpha

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 11, 2017-11 ,pp. : 1843-1847

John Wiley & Sons Inc

Access to resources Recommend Favorite

Polymorphisms within the human leucocyte antigen‐E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti‐tumour necrosis factor therapy

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 3, 2015-12 ,pp. : 270-277

John Wiley & Sons Inc

Access to resources Recommend Favorite